How a Drug Helps Livers Burn Fat Better

Original Title

The PPARβ/δ activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1α-Lipin 1-PPARα pathway leading to increased fatty acid oxidation.

Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms

Summary

Mice eating too much fat had lazy livers that stored fat instead of burning it. A drug called GW501516 woke up the fat-burning system in their liver cells.

Sign up to see full results

Get access to research results, context, and detailed analysis.

Surprising Findings

GW501516 increased levels of 16:0/18:1-phosphatidylcholine, an endogenous PPARα ligand, in the liver.

The drug didn’t just activate PPARα directly—it boosted the liver’s own natural activator, creating a self-reinforcing fat-burning signal.

Practical Takeaways

Support your liver’s fat-burning pathways with lifestyle choices that activate AMPK and PPARα, like exercise and intermittent fasting.

medium confidence

Unlock Full Study Analysis

Sign up free to access quality scores, evidence strength analysis, and detailed methodology breakdowns.